Sales and Marketing

CAR T cell therapy is one of the latest innovations in gene therapy. The process is primarily used to treat …

Novartis’ interleukin-17A (IL-17A) inhibitor Cosentyx (secukinumab) has chalked up approval from the European Commission (EC) for the treatment of patients …

The EU has reached an agreement with Sanofi for 300 million doses of their COVID-19 vaccine candidate which will allow …

Two new coronavirus tests are set to be made available throughout England that are significantly faster than most already in …

The FDA has awarded MorphoSys and Incyte US approval for their Fc-modified cytolytic CD19-targeting monoclonal antibody Monjuvi (tafasitamab-cxix), when used …

The FDA has approved Epidiolex (cannabidiol) as a treatment for seizures associated with tuberous sclerosis complex (TSC) in patients over …

Another week dominated by COVID-19. Among our most popular stories this week, Celltrion’s infliximab biosimilar Remsima has scored approval for …

Janssen’s IL-12 and IL-23 inhibitor Stelara (ustekinumab) has had its approved indications expanded by the FDA to include the treatment …

NICE has revealed that a combination of Merck KGaA’s Bavencio (avelumab) and Pfizer’s Inlyta (axitinib) will be made available as …

UCB Pharma is set to partner up with Roche and Genentech in a development and commercialisation deal focused on its …

NICE has issued draft guidance that has shot down Kyowa Kirin’s therapy Poteligeo (mogamulizumab) for use on the NHS in …

Japan’s biggest drug firm Takeda is said to be mulling plans to cut back its sales operations with a new …

The once-touted COVID cure hydroxychloroquine continues its downward spiral of credibility as new data is published on its lack of …

The European Commission (EC) has awarded its approval for Novartis’ Piqray (alpelisib) to be made available in combination with fulvestrant …

The UK Government has sealed another deal to procure an effective COVID-19 vaccine for its citizens, partnering up with Sanofi …